DNA methylation patterns at birth predict health outcomes in young adults born very low birthweight
Clinical Epigenetics · 13 authors, 5 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This longitudinal cohort study analyzed DNA methylation at birth and at 28 years in individuals born very low birthweight (VLBW) versus controls. It found that neonatal methylation differences were associated with adult cardiovascular and respiratory traits.
Full summary
738 CHARS
The study analyzed genomic DNA from archived neonatal blood spots (109 VLBW, 51 controls) and adult peripheral blood (~28 years; 215 VLBW, 96 controls) using Illumina MethylationEPIC arrays. Linear regression identified differentially methylated CpGs between groups, with genome-wide significance set to p<0.05 (FDR-adjusted). In neonates, over 16,400 CpGs differed, with the top pathway being Cardiac Hypertrophy Signaling. In adults, 12 CpGs differed, including in EBF4 and HIF3A. Four CpGs differed at both ages, with three reversing direction. Neonatal methylation at cg16426670 in EBF4 was associated with multiple adult cardiovascular traits. The findings suggest neonatal methylation may predict future adult cardiovascular health.